As of 2024-12-14, the Fair Value of Arrowhead Pharmaceuticals Inc (ARWR) is -24.11 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 21.85 USD, the upside of Arrowhead Pharmaceuticals Inc is -210.35%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 5Y Avg | |
| Net income | -84.60 | -140.80 | -176.10 | -205.30 | -599.49 | -241.26 |
| YoY growth | -224.41% | -66.43% | -25.07% | -16.58% | -192.01% | -104.90% |
| Market Cap (mil) | 2,716.39 |
| P/E | |
| Forward P/E |
| EPS | -4.82 |
| Avg earnings growth rate | -104.90% |
| TTM earnings | -599.49 |